Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10842184rdf:typepubmed:Citationlld:pubmed
pubmed-article:10842184lifeskim:mentionsumls-concept:C1334291lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C0034839lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C0815047lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C1160192lld:lifeskim
pubmed-article:10842184lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:10842184pubmed:issue36lld:pubmed
pubmed-article:10842184pubmed:dateCreated2000-10-13lld:pubmed
pubmed-article:10842184pubmed:abstractTextSignal regulatory proteins (SIRPs) are receptor-like transmembrane proteins, the majority of which contain a cytoplasmic proline-rich region and four cytoplasmic tyrosines that, when phosphorylated, bind SH2 domain-containing protein tyrosine phosphatases (SHP). We demonstrated previously that growth hormone (GH) induces tyrosyl phosphorylation of SIRPalpha and association of SIRPalpha with SHP-2. The GH-activated tyrosine kinase JAK2 associates with and tyrosyl-phosphorylates SIRPalpha1. Here we show that JAK2-SIRPalpha1 association does not require phosphotyrosines in SIRPalpha1 or JAK2 or the proline-rich region of SIRPalpha1. However, when the C-terminal 30 amino acids of SIRPalpha1 containing the proline-rich region and tyrosine 495 are deleted, tyrosyl phosphorylation of SIRPalpha1 by JAK2 and association of SHP-2 with SIRPalpha1 are reduced. GH-dependent tyrosyl phosphorylation of JAK2 is reduced when wild-type SIRPalpha1 compared with SIRPalpha1 lacking the four cytoplasmic tyrosines (SIRP 4YF) is expressed in cells, suggesting that SIRPalpha1 negatively regulates GHR/JAK2 signaling. Consistent with reduced JAK2 activity, overexpression of wild-type SIRPalpha1 but not SIRP 4YF reduces GH-induced phosphorylation of ERKs 1 and 2, STAT3, and STAT5B. These results suggest that SIRPalpha1 is a negative regulator of GH signaling and that the ability of SIRPalpha1 mutants to negatively regulate GHR-JAK2 signaling correlates with their ability to bind SHP-2.lld:pubmed
pubmed-article:10842184pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:languageenglld:pubmed
pubmed-article:10842184pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:citationSubsetIMlld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10842184pubmed:statusMEDLINElld:pubmed
pubmed-article:10842184pubmed:monthSeplld:pubmed
pubmed-article:10842184pubmed:issn0021-9258lld:pubmed
pubmed-article:10842184pubmed:authorpubmed-author:UllrichAAlld:pubmed
pubmed-article:10842184pubmed:authorpubmed-author:WangHHlld:pubmed
pubmed-article:10842184pubmed:authorpubmed-author:Carter-SuCClld:pubmed
pubmed-article:10842184pubmed:authorpubmed-author:ArgetsingerL...lld:pubmed
pubmed-article:10842184pubmed:authorpubmed-author:StofegaM RMRlld:pubmed
pubmed-article:10842184pubmed:issnTypePrintlld:pubmed
pubmed-article:10842184pubmed:day8lld:pubmed
pubmed-article:10842184pubmed:volume275lld:pubmed
pubmed-article:10842184pubmed:ownerNLMlld:pubmed
pubmed-article:10842184pubmed:authorsCompleteYlld:pubmed
pubmed-article:10842184pubmed:pagination28222-9lld:pubmed
pubmed-article:10842184pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:meshHeadingpubmed-meshheading:10842184...lld:pubmed
pubmed-article:10842184pubmed:year2000lld:pubmed
pubmed-article:10842184pubmed:articleTitleNegative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.lld:pubmed
pubmed-article:10842184pubmed:affiliationDepartment of Microbiology and Immunology and Department of Physiology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.lld:pubmed
pubmed-article:10842184pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10842184pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:10842184pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3717entrezgene:pubmedpubmed-article:10842184lld:entrezgene
entrez-gene:140885entrezgene:pubmedpubmed-article:10842184lld:entrezgene
entrez-gene:16452entrezgene:pubmedpubmed-article:10842184lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:10842184lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10842184lld:pubmed
More...